RIMEGEPANT SULFATE

N/A

Manufactured by Pfizer Laboratories Div Pfizer Inc

19,247 FDA adverse event reports analyzed

Last updated: 2026-04-14

About RIMEGEPANT SULFATE

RIMEGEPANT SULFATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Pfizer Laboratories Div Pfizer Inc. The most commonly reported adverse reactions for RIMEGEPANT SULFATE include DRUG INEFFECTIVE, NAUSEA, MIGRAINE, HEADACHE, THERAPEUTIC PRODUCT EFFECT INCOMPLETE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for RIMEGEPANT SULFATE.

Top Adverse Reactions

DRUG INEFFECTIVE3,968 reports
NAUSEA1,116 reports
MIGRAINE806 reports
HEADACHE733 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE639 reports
OFF LABEL USE473 reports
DIZZINESS431 reports
FATIGUE410 reports
VOMITING348 reports
FEELING ABNORMAL314 reports
SOMNOLENCE271 reports
RASH265 reports
PAIN263 reports
PRODUCT DOSE OMISSION ISSUE261 reports
PRURITUS236 reports
ABDOMINAL PAIN UPPER235 reports
THERAPEUTIC PRODUCT EFFECT DECREASED233 reports
HYPERSENSITIVITY214 reports
COVID 19206 reports
ANXIETY202 reports
DYSPNOEA201 reports
DIARRHOEA196 reports
CONSTIPATION182 reports
ABDOMINAL DISCOMFORT181 reports
ILLNESS179 reports
THERAPEUTIC PRODUCT EFFECT VARIABLE178 reports
MALAISE174 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION171 reports
INJECTION SITE PAIN158 reports
EXPOSURE DURING PREGNANCY151 reports
INSOMNIA147 reports
DYSPEPSIA143 reports
DRUG HYPERSENSITIVITY136 reports
ARTHRALGIA129 reports
THERAPEUTIC PRODUCT EFFECT DELAYED129 reports
PARAESTHESIA128 reports
URTICARIA128 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION117 reports
HYPOAESTHESIA112 reports
ALOPECIA109 reports
CONDITION AGGRAVATED109 reports
THERAPEUTIC RESPONSE SHORTENED109 reports
ASTHENIA103 reports
HYPERTENSION103 reports
BLOOD PRESSURE INCREASED99 reports
DEPRESSION98 reports
FALL97 reports
INCORRECT DOSE ADMINISTERED97 reports
PALPITATIONS96 reports
WEIGHT DECREASED96 reports
UNEVALUABLE EVENT93 reports
ABDOMINAL PAIN92 reports
CHEST PAIN90 reports
URINARY TRACT INFECTION90 reports
MATERNAL EXPOSURE DURING PREGNANCY89 reports
MUSCLE SPASMS89 reports
VERTIGO86 reports
WEIGHT INCREASED86 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS86 reports
CHEST DISCOMFORT85 reports
GASTROINTESTINAL DISORDER84 reports
BACK PAIN83 reports
DEATH81 reports
PAIN IN EXTREMITY81 reports
FOETAL EXPOSURE DURING PREGNANCY80 reports
SINUSITIS80 reports
TREMOR79 reports
HEART RATE INCREASED76 reports
VISUAL IMPAIRMENT76 reports
COUGH75 reports
PRODUCT USE IN UNAPPROVED INDICATION75 reports
DRUG EFFECT LESS THAN EXPECTED73 reports
GASTROOESOPHAGEAL REFLUX DISEASE73 reports
VISION BLURRED73 reports
ASTHMA72 reports
MEMORY IMPAIRMENT72 reports
NASOPHARYNGITIS72 reports
ADVERSE DRUG REACTION71 reports
SEIZURE71 reports
THERAPEUTIC RESPONSE UNEXPECTED71 reports
LOSS OF CONSCIOUSNESS69 reports
PRODUCT ADMINISTRATION INTERRUPTED69 reports
DRUG INTERACTION63 reports
SUICIDAL IDEATION63 reports
DECREASED APPETITE61 reports
PRODUCT USE ISSUE61 reports
SURGERY61 reports
ERYTHEMA60 reports
NECK PAIN60 reports
TINNITUS59 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES56 reports
PYREXIA56 reports
DRY MOUTH54 reports
FLUSHING54 reports
HEAD DISCOMFORT54 reports
EYE PAIN53 reports
PNEUMONIA53 reports
PRODUCT USE COMPLAINT53 reports
DYSGEUSIA52 reports
HYPERHIDROSIS52 reports

Report Outcomes

Out of 11,905 classified reports for RIMEGEPANT SULFATE:

Serious 17.7%Non-Serious 82.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female7,807 (86.4%)
Male1,222 (13.5%)
Unknown4 (0.0%)

Reports by Age

Age 54160 reports
Age 52158 reports
Age 61154 reports
Age 44150 reports
Age 53150 reports
Age 60149 reports
Age 50147 reports
Age 51147 reports
Age 59147 reports
Age 56145 reports
Age 43143 reports
Age 55142 reports
Age 58137 reports
Age 45136 reports
Age 40135 reports
Age 42135 reports
Age 57135 reports
Age 62135 reports
Age 48133 reports
Age 47129 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with RIMEGEPANT SULFATE?

This profile reflects 19,247 FDA FAERS reports that mention RIMEGEPANT SULFATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for RIMEGEPANT SULFATE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, NAUSEA, MIGRAINE, HEADACHE, THERAPEUTIC PRODUCT EFFECT INCOMPLETE, OFF LABEL USE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures RIMEGEPANT SULFATE?

Labeling and FAERS entries often list Pfizer Laboratories Div Pfizer Inc in connection with RIMEGEPANT SULFATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.